Xcelerate Inc.

XCRT

US98401T1051

Healthcare Facilities & Services

Delayed OTC Markets Other stock markets 10:19:32 2024-05-02 am EDT			5-day change	1st Jan Change
0.03 ^USD	-8.70%		-14.29%	-16.67%

2023	Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	CI
2023	Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	CI

Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023

September 22, 2023 at 06:17 am EDT

Xcelerate Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was USD 1.8 million compared to USD 0.776017 million a year ago.

Latest news about Xcelerate Inc.

Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	Nov. 13	CI
Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	23-10-24	CI
Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-22	CI
Xcelerate Announces Marketing Agreement with ProductSector, LLC	23-08-08	CI
Xcelerate Inc. acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.	23-07-23	CI
Xcelerate Inc. completed the acquisition of an unknown majority stake in ESN Group, Inc.	23-07-19	CI
Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Xcelerate Inc. Auditor Raises 'Going Concern' Doubt	23-04-27	CI
Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board	23-02-01	CI
Xcelerate Inc. entered into a letter of intent to acquire an unknown majority stake in ESN Group, Inc.	23-01-16	CI
Xcelerate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-15	CI
Fran White Joins the Advisory Board of Xcelerate, Inc	22-02-15	CI
Xcelerate Inc. signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC.	22-01-02	CI
Xcelerate Inc. signed a non-binding letter of intent to acquire HS Pharmaceuticals, LLC.	21-05-05	CI
Xcelerate Inc. Appoints Vincent C. du Vigneaud, to the Advisory Board	21-04-27	CI
Union Dental Holdings Inc. has Changed its Name to Xcelerate, Inc	21-03-17	CI
Xcelerate, Inc Appoints Barry James Marshall to its Advisory Board	21-02-23	CI
Xcelerate, Inc. Appoints Dilantha B. Ellegala to the Advisory Board	21-02-08	CI
Union Dental Holdings, Inc. Announces Preliminary Agreement for Medical Patent	20-09-11	CI
Union Dental Holdings, Inc. Names Dr. Anja Glisovic as Chief Science Officer	20-09-04	CI
Union Dental Holdings Appoints Jason Householder as Board of Directors	20-08-04	CI
Union Dental Holdings Announces Steve Gravely as Board Member	20-07-23	CI
Union Dental Holdings Appoints Michael F. O’Shea as Interim President and Sole Director	20-07-16	CI
Union Dental Holdings Inc. cancelled the acquisition of remaining stake in Drinkable Air, Inc.	15-12-17	CI
Union Dental Holdings Inc. Announces Consolidated Financial Results for the First Quarter Ended March 31, 2015	15-05-08	CI

Xcelerate, Inc. seeks to acquire technology/healthcare business. The Companyâs business plan encompasses three separate but related businesses within the medical, health and wellness sectors, including owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses; formulation, packaging and marketing of over the counter, clinically tested skin care products, and development of virtual health technology to assist patients in developing countries, initially in Africa, to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
XCELERATE INC.	-16.67%	14.28M
HCA HEALTHCARE, INC.	+14.76%	81.84B
CVS HEALTH CORPORATION	-31.90%	70.69B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.37%	29.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-11.76%	16.97B
FRESENIUS SE & CO. KGAA	-0.04%	16.83B
QUEST DIAGNOSTICS INCORPORATED	-1.39%	15.28B
FRESENIUS MEDICAL CARE AG	+6.19%	12.41B
DAVITA INC.	+35.18%	12.26B
EUROFINS SCIENTIFIC SE	-3.93%	11.86B